Trinity Biotech (TRIB) Operating Income Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Operating Income Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 74.18% |
| 10 | Trinity Biotech | 105.39 Mn | 100.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -204.66% |
| Sep 30, 2024 | 43.16% |
| Jun 30, 2024 | 72.72% |
| Mar 31, 2024 | 22.40% |
| Dec 31, 2023 | 53.67% |
| Sep 30, 2023 | 44.66% |
| Jun 30, 2023 | -702.81% |
| Mar 31, 2023 | -222.29% |
| Dec 31, 2022 | -1,548.85% |
| Sep 30, 2022 | -393.75% |
| Jun 30, 2022 | -948.62% |
| Mar 31, 2022 | -139.51% |
| Dec 31, 2021 | -93.79% |
| Sep 30, 2021 | -69.53% |
| Jun 30, 2021 | -56.49% |
| Mar 31, 2021 | 81.81% |
| Dec 31, 2020 | 527.84% |
| Sep 30, 2020 | 581.55% |
| Jun 30, 2020 | -58.42% |
| Mar 31, 2020 | 28.26% |